PA
PROF

Parallel Advisors’s Profound Medical PROF Stock Holding History

Parallel Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194 Hold
30
– – ﹤0.01% 3752
2025
Q4 		$236 Hold
30
– – ﹤0.01% 3500
2025
Q3 		$147 Hold
30
– – ﹤0.01% 3463
2025
Q2 		$177 Sell
30
-50
-63% -$264 ﹤0.01% 3426
2025
Q1 		$466 Buy
80
+50
+167% +$345 ﹤0.01% 3246
2024
Q4 		$225 Hold
30
– – ﹤0.01% 3362
2024
Q3 		$239 Hold
30
– – ﹤0.01% 3278
2024
Q2 		$252 Hold
30
– – ﹤0.01% 3177
2024
Q1 		$256 Hold
30
– – ﹤0.01% 3132
2023
Q4 		$255 Hold
30
– – ﹤0.01% 3141
2023
Q3 		$306 Hold
30
– – ﹤0.01% 3186
2023
Q2 		$390 Hold
30
– – ﹤0.01% 3150
2023
Q1 		$279 Hold
30
– – ﹤0.01% 3241
2022
Q4 		$327 Hold
30
– – ﹤0.01% 3113
2022
Q3 		$0 Hold
30
– – ﹤0.01% 3419
2022
Q2 		$0 Hold
30
– – ﹤0.01% 3277
2022
Q1 		$0 Buy
+30
New +$289 ﹤0.01% 3210

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Parallel Advisors's PROF Position: Q1 2026 in Review

Parallel Advisors held its Profound Medical (PROF) position steady in Q1 2026 at 30 shares worth $194. The position accounts for ﹤0.01% of the portfolio, ranked #3752.

Parallel Advisors first reported a position in PROF in Q1 2022 and has held it in 17 quarters since. The position peaked at $466 in Q1 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Parallel Advisors held 30 shares of Profound Medical worth $194 as of Q1 2026.
  • Parallel Advisors left its Profound Medical share count unchanged in Q1 2026.
  • Profound Medical made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3752 holding.
  • Parallel Advisors first reported a position in Profound Medical in Q1 2022 and has held it in 17 quarters since.
  • Parallel Advisors's Profound Medical position peaked at $466 in Q1 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.